Home > Events > Educational > Webinars > webinars EURO-NMD > Multifocal motor neuropathy (MMN): diagnosis, treatment and update on biomarkers
A A A

Multifocal motor neuropathy (MMN): diagnosis, treatment and update on biomarkers

13 Feb 2025

Online

Online

…TIMESLOT: Thursday 13 February 2025 16:00 CET

…THEME: Multifocal motor neuropathy (MMN): diagnosis, treatment and update on biomarkers

…PRESENTERS: Prof. Thomas Harbo (Aarhus University, Denmark) & Dr. Emilien Delmont (AP-HM Hôpital de la Timone, Marseille, France)

 

Thomas Harbo is a neuromuscular specialist at Aarhus University Hospital in Aarhus, Denmark, a certified Centre of Excellence by the GBS|CIDP Foundation International. His neurology training was at Aarhus University Hospital and he has completed a neuromuscular fellowship at Johns Hopkins Hospital in Baltimore, MD, USA. His Clinical and academic interest is focused on acute and chronic inflammatory neuropathies including Guillian-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). He is secretary at the Inflammatory Neuropathy Consortium a special interest group of the Peripheral Nervous Society and a member of the Global Medical Advisory Board of GBS-CIDP Foundation International.

 

Delmont Emilien is a neurologist. He graduated his MD and PhD from the University of Nice, France. He completed his post-doctoral studies at the University of Glasgow, Scotland UK. He works at the Referral Center for Neuromuscular Diseases and ALS in Marseille, France. He is specialized in autoimmune neuropathies: CIDP, MMN, anti-MAG neuropathy and nodopathy with antibodies against the node of Ranvier.